LLY logo

LLY

Eli Lilly and Company

$732.58
+$0.62(+0.08%)
42
Overall
45
Value
40
Tech
--
Quality
Market Cap
$696.62B
Volume
2.55M
52W Range
$623.78 - $969.65
Target Price
$905.46
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$20.0B$21.2B$22.9B$21.5B$22.3B$24.5B$28.3B$28.5B$34.1B$45.0B
Total Revenue
$20.0B$21.2B$22.9B$21.5B$22.3B$24.5B$28.3B$28.5B$34.1B$45.0B
COST OF GOODS SOLD
Cost of Revenue
$5.0B$5.7B$6.2B$4.7B$4.7B$5.5B$7.3B$6.6B$7.1B$8.4B
GROSS PROFIT
Gross Profit
$14.9B$15.6B$16.7B$16.8B$17.6B$19.1B$21.0B$21.9B$27.0B$36.6B
OPERATING EXPENSES
Operating Expenses
$11.3B$11.7B$12.0B$11.0B$11.8B$12.2B$13.4B$13.3B$20.5B$22.9B
Research & Development
$4.8B$5.2B$5.4B$5.1B$5.6B$6.1B$6.9B$8.1B$13.1B$14.3B
Research Expense
$4.8B$5.2B$5.4B$5.1B$5.6B$6.1B$6.9B$7.2B$9.3B$11.0B
Selling, General & Administrative
$6.5B$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B
Selling & Marketing Expenses
------$900.0M$1.1B$1.1B$1.2B$966.8M$1.1B$1.4B
General & Administrative Expenses
$6.5B$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B
Promotion & Advertising
------$900.0M$1.1B$1.1B$1.2B------
Salaries & Wages
$-76.2M$-89.4M$-70.5M$-53.2M$-64.4M$-64.7M$-72.0M------
Depreciation & Amortization
$1.4B$716.2M$763.1M$797.1M$814.7M$765.2M$787.0M$816.6M$1.5B$1.8B
Depreciation & Amortization
$1.4B$716.2M$763.1M$797.1M$814.7M$765.2M$787.0M------
Amortization
$5.0B$4.4B$4.4B$1.4B$6.6B$7.5B$7.7B$7.2B$6.9B$6.2B
Other Operating Expenses
$-131.3M$-73.4M$-133.8M$-798.2M$-187.2M$-225.6M$-310.3M------
OPERATING INCOME
Operating income
$3.6B$3.9B$4.7B$5.8B$5.8B$6.8B$7.6B$7.4B$6.5B$13.8B
EBITDA
$4.2B$4.9B$3.8B$5.3B$6.6B$8.9B$8.0B$8.7B$8.6B$15.2B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$161.2M$185.2M$225.0M$242.5M$400.6M$359.6M$339.8M$331.6M$485.9M$780.6M
Intinc
$87.0M$108.7M$167.3M$159.3M$80.4M$33.0M$25.4M$62.8M$173.6M$175.2M
Net Non-Operating Interest Income/Expense
$-74.2M$-76.5M$-57.7M$-83.2M$-320.2M$-326.6M$-314.4M$-268.8M$173.6M$175.2M
Gain on Sale of Securities
$255.1M$30.7M$176.0M$20.1M$-401.2M$1.4B$176.9M$-410.7M$-20.2M$-49.5M
Other Income/Expense
$-100.6M$84.8M$-300.5M$-145.6M$-291.6M$-1.2B$201.6M$-1.6B$-96.7M$218.6M
Other Special Charges
$100.6M$-84.8M$300.5M$145.6M$291.6M$1.2B$-201.6M$-320.9M$96.7M$-218.6M
SPECIAL ITEMS
Restructring And Mn A Income
$367.7M$382.5M$1.7B$266.9M$575.6M$131.2M$316.1M$244.6M$67.7M$860.6M
Special Income Charges
$-367.7M$-382.5M$-1.7B$-266.9M$-575.6M$-131.2M$-316.1M$-244.6M$-67.7M$-860.6M
Other Impairment Of Capital Assets
$42.6M$53.0M$50.0M------$108.1M------
PRE-TAX INCOME
EBIT
$2.8B$3.4B$2.2B$3.7B$5.4B$7.6B$6.5B$7.1B$7.0B$13.5B
Pre-Tax Income
$2.8B$3.4B$2.2B$3.7B$5.3B$7.2B$6.2B$6.8B$6.6B$12.7B
INCOME TAX
Tax Provision
$381.6M$636.4M$2.4B$529.5M$628.0M$1.0B$573.8M$561.6M$1.3B$2.1B
NET INCOME
Net Income
$2.4B$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B
Net Income (Continuing Operations)
$2.4B$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B
Net Income (Discontinued Operations)
$2.4B$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B
Net Income (Common Stockholders)
$2.9B$2.8B$908.5M$5.2B$8.6B$6.2B$5.6B$6.2B$5.2B$10.6B
Normalized Income
$2.2B$2.9B$3.3B$3.2B$1.1B$5.8B--------
TOTALS
Total Expenses
$16.4B$17.4B$18.2B$15.7B$16.5B$17.7B$20.7B$19.9B$27.6B$31.3B
SHARE & EPS DATA
Average Shares Outstanding
$1.1B$1.1B$1.1B$1.0B$931.1M$907.6M$907.0M$901.7M$900.2M$900.6M
Average Shares Outstanding (Diluted)
$1.1B$1.1B$1.1B$1.0B$935.7M$912.5M$911.7M$904.6M$903.3M$904.1M
Shares Outstanding
$1.1B$1.1B$1.1B$1.0B$956.4M$958.4M$952.3M$950.3M$950.2M$948.2M
Basic EPS
$2.27$2.59$-0.19$3.14$8.93$6.82$6.15$6.93$5.82$11.76
Basic EPS (Continuing Operations)
$2.27$2.59$-0.19$3.14$4.98$6.82$6.15$6.93$5.82$11.76
Diluted EPS
$2.26$2.58$-0.19$3.13$8.89$6.79$6.12$6.9$5.8$11.71
Diluted EPS (Continuing Operations)
$2.26$2.58$-0.19$3.13$4.96$6.79$6.12$6.9$5.8$11.71
Dividend Per Share
------$2.33$2.68$3.07$3.53$3.92$4.52$5.4
OTHER METRICS
Basic Discontinuous Operations
--------$3.95----------
Development Expense
--------------$908.5M$3.8B$3.3B
Diluted Discontinuous Operations
--------$3.93----------
Earnings from equity interest
$-2.1B$-2.2B$-2.2B--------------
Earnings From Equity Interest Net Of Tax
$-2.1B$-2.2B$-2.2B--------------
Gain On Sale Of Business
--------$3.7B----------
Gains Loss On Disposal Of Discontinued Operations
--------$309.8M----------
Interest Expense Operating
$-129.6M$-146.4M$-192.7M$-223.8M$-305.5M$-345.8M$-338.0M------
Minority Interests
$14.6B$14.1B$11.7B$10.9B$2.7B$5.8B--------
Net Income Discontinuous Operations
------$81.4M$3.7B----------
Other Gain Loss From Disposition Of Discontinued Operations
------$81.4M$3.7B----------
Other Gand A
$6.5B$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B
Rent And Landing Fees
$225.7M$221.0M$224.5M$175.7M------------
Restruct
$367.7M$382.5M$1.7B$266.9M$575.6M$131.2M$316.1M$244.6M$67.7M$860.6M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2LLY$732.58+0.1%2.55M
3
4
5
6

Get Eli Lilly and Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.